Insider trading

Period: 120 months Stock: EXEL + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

404 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

404 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

404 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

404 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
404 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
404 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

404 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
14 Feb 2025
Beckerle Mary C Director
Sold at will 2×
$425.88K 12,210 at 34.88
28.7%
Not planned
14 Feb 2025
Sold on a plan 2×
$405.11K 11,568 at 35.02
27.6%
Planned (10b5-1)
29 Nov 2024
Hessekiel Jeffrey EVP & General Counsel
Sold at will
$2.20M 60,000 at 36.67
11.0%
Not planned
22 Nov 2024
Haley Patrick J. EVP, Commercial
Sold on a plan
$352.70K 10,000 at 35.27
3.5%
Planned (10b5-1)
18 Nov 2024
Haley Patrick J. EVP, Commercial
Sold on a plan 2×
$1.43M 41,588 at 34.36
12.6%
Planned (10b5-1)
5 Nov 2024
Aftab Dana CSO/EVP Disc & Trans Research
Sold on a plan
$3.39M 96,986 at 35.00
16.3%
Planned (10b5-1)
1 Nov 2024
Hessekiel Jeffrey EVP & General Counsel
Sold on a plan
$1.71M 50,000 at 34.13
8.6%
Planned (10b5-1)
1 Nov 2024
POSTE GEORGE Director
Sold at will
$1.02M 30,000 at 34.00
15.1%
Not planned
30 Oct 2024
Aftab Dana CSO/EVP Disc & Trans Research
Sold on a plan
$36.49K 1,162 at 31.40
0.2%
Planned (10b5-1)
28 Oct 2024
Hessekiel Jeffrey EVP & General Counsel
Sold on a plan
$709.75K 25,000 at 28.39
4.1%
Planned (10b5-1)
23 Sep 2024
Hessekiel Jeffrey EVP & General Counsel
Sold on a plan
$659.50K 25,000 at 26.38
4.0%
Planned (10b5-1)
26 Aug 2024
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$515.80K 20,000 at 25.79
3.1%
Planned (10b5-1)
14 Aug 2024
Freire Maria C Director
Sold at will
$219.12K 8,250 at 26.56
8.3%
Not planned
12 Aug 2024
Aftab Dana CSO/EVP Disc & Trans Research
Sold at will
$565.09K 20,883 at 27.06
4.0%
Not planned
9 Aug 2024
Senner Christopher J. EVP and CFO
Sold at will
$3.40M 125,000 at 27.19
14.8%
Not planned
8 Aug 2024
POSTE GEORGE Director
Sold at will
$906.87K 33,725 at 26.89
14.5%
Not planned
7 Aug 2024
Aftab Dana CSO/EVP Disc & Trans Research
Sold on a plan
$2.38M 95,000 at 25.00
15.4%
Planned (10b5-1)
7 Aug 2024
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$2.08M 80,000 at 25.97
11.3%
Planned (10b5-1)
7 Aug 2024
Haley Patrick J. EVP, Commercial
Sold on a plan
$357.00K 14,000 at 25.50
3.9%
Planned (10b5-1)
4 Jun 2024
Sold on a plan
$182.31K 8,287 at 22.00
2.3%
Planned (10b5-1)
30 May 2024
JOHNSON DAVID EDWARD Director · indirect
Bought
$4.67M 225,000 at 20.76
17.3%
Largest buy in 3 yrs
28 May 2024
JOHNSON DAVID EDWARD Director · indirect
Bought
$4.06M 200,000 at 20.32
18.2%
Largest buy in 3 yrs
21 May 2024
Smith Julie Director
Sold at will
$576.15K 27,280 at 21.12
83.4%
Sold half or more
21 May 2024
POSTE GEORGE Director
Sold at will
$244.94K 11,686 at 20.96
5.2%
Not planned
20 May 2024
Sold at will
$240.18K 11,437 at 21.00
0.9%
Not planned
13 May 2024
Sold on a plan
$233.42K 10,923 at 21.37
3.1%
Planned (10b5-1)
21 Mar 2024
Garber Alan M Director
Sold on a plan
$461.11K 19,205 at 24.01
35.0%
Planned (10b5-1)
23 Feb 2024
Haley Patrick J. EVP, Commercial
Sold at will
$1.01M 47,020 at 21.45
10.9%
Not planned
21 Feb 2024
JOHNSON DAVID EDWARD Director · indirect
Bought
$3.93M 190,000 at 20.70
20.9%
Largest buy in 3 yrs
14 Dec 2023
Haley Patrick J. EVP, Commercial
Sold on a plan
$1.17M 50,000 at 23.35
14.0%
Planned (10b5-1)
13 Dec 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$575.25K 25,000 at 23.01
4.5%
Planned (10b5-1)
12 Dec 2023
Haley Patrick J. EVP, Commercial
Sold on a plan
$318.35K 14,149 at 22.50
4.4%
Planned (10b5-1)
4 Dec 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$551.50K 25,000 at 22.06
4.3%
Planned (10b5-1)
30 Nov 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$550.25K 25,000 at 22.01
4.1%
Planned (10b5-1)
27 Nov 2023
JOHNSON DAVID EDWARD Director · indirect
Bought
$2.60M 120,409 at 21.61
15.2%
First buy on file
27 Nov 2023
JOHNSON DAVID EDWARD Director · indirect
Sold at will
$2.60M 120,409 at 21.61
13.2%
Not planned
30 Aug 2023
Aftab Dana CSO/EVP Disc & Trans Research
Sold on a plan
$103.36K 4,600 at 22.47
1.1%
Planned (10b5-1)
4 Aug 2023
Senner Christopher J. EVP and CFO
Sold at will
$1.24M 60,000 at 20.68
9.5%
Not planned
3 Aug 2023
Senner Christopher J. EVP and CFO
Sold at will
$1.23M 60,000 at 20.51
9.5%
Not planned
3 Aug 2023
Haley Patrick J. EVP, Commercial
Sold at will
$631.53K 30,553 at 20.67
9.7%
Not planned
1 Aug 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$1.09M 55,710 at 19.63
8.9%
Planned (10b5-1)
5 Apr 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold on a plan
$778.99K 38,930 at 20.01
6.3%
Planned (10b5-1)
10 Mar 2023
Sold, plan not stated
$254.13K 15,300 at 16.61
4.6%
1 Mar 2023
Hessekiel Jeffrey EVP, General Counsel & Sec
Sold, plan not stated
$1.33M 77,860 at 17.13
12.9%
28 Feb 2023
Aftab Dana CSO/EVP Disc & Trans Research
Sold, plan not stated
$1.44M 82,490 at 17.50
19.0%
27 Feb 2023
Aftab Dana CSO/EVP Disc & Trans Research
Sold, plan not stated
$175.00 10 at 17.50
0.0%
21 Feb 2023
Garber Alan M Director
Sold, plan not stated
$699.60K 40,000 at 17.49
56.0%
Sold half or more
9 Feb 2023
FELDBAUM CARL B Director
Sold, plan not stated
$711.20K 40,000 at 17.78
68.1%
Sold half or more
6 Feb 2023
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$434.25K 25,000 at 17.37
8.9%
15 Dec 2022
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$317.60K 20,000 at 15.88
4.6%
Showing 51–100 of 404. ← Newer Page 2 of 9 Older →